Vor Biopharma Inc.

0.97
-0.11 (-10.19%)
At close: Mar 03, 2025, 3:59 PM
0.95
-2.14%
After-hours: Mar 03, 2025, 04:00 PM EST

Vor Biopharma Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -117.86M -92.09M -68.9M -43.34M -10.84M -4.15M
Depreciation & Amortization 3.49M 2.52M 1.43M 605K 91K 20K
Stock-Based Compensation 13.36M 10.7M 4.32M 1.34M 172K 116K
Other Working Capital -2.2M -12.69M -9.59M -1.5M -1.07M 63K
Other Non-Cash Items 67K 6.42M 3.19M 782K 608K 1M
Deferred Income Tax n/a n/a n/a n/a -32K 289K
Change in Working Capital 650K -12.69M -9.19M 4.32M 145K 63K
Operating Cash Flow -100.29M -85.14M -69.14M -36.29M -9.86M -2.66M
Capital Expenditures -1.07M -8.46M -3.89M -4.16M -748K n/a
Acquisitions n/a n/a n/a n/a n/a n/a
Purchase of Investments -74.92M -123.19M -87.76M n/a n/a n/a
Sales Maturities Of Investments 147M 37.56M n/a n/a n/a n/a
Other Investing Acitivies n/a -0.00 -87.76K n/a n/a n/a
Investing Cash Flow 71.01M -94.09M -91.65M -4.16M -748K n/a
Debt Repayment n/a n/a n/a n/a n/a 2.46M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -1.64M 1.17M 43.71M 82.53M 17.7M n/a
Financial Cash Flow 2.94M 117.14M 232.91M 82.53M 17.7M 2.46M
Net Cash Flow -26.35M -62.09M 72.12M 42.07M 7.1M -197K
Free Cash Flow -101.36M -93.61M -73.04M -40.45M -10.6M -2.66M